News
Canada as a Global Cannabis Policy Laboratory
Since legalizing adult-use cannabis in 2018, Canada has become a key case study for researchers examining the effects of nationwide cannabis legalization. As the first G-7 nation to implement such a policy, Canada provides insights into public behavior, market dynamics, and regulatory outcomes. Key Findings from Recent Survey A recent survey conducted by Abacus Data in partnership with Organigram Global Inc. asked Canadian adults about their cannabis use and perceptions of the economic value of the legal industry. Some of the most notable findings include: 35% of Canadian adults reported using cannabis in the past six months. 32% reported use...
U.S. Hemp Industry Faces Crackdown: Is Europe the Next Frontier?
The United States consumable hemp market has experienced remarkable growth since the passage of the 2018 Farm Bill, which federally legalized hemp production. While all segments of the hemp sector benefitted, none expanded more explosively than the floral hemp category and the wide range of products derived from it. In states without legalized adult-use cannabis, hemp-derived consumables filled a critical gap for consumers and patients. A thriving market rapidly emerged—particularly for cannabinoid-rich products extracted from floral hemp—which became widely available even where cannabis remains prohibited. A Booming Industry Faces Sudden Reversal According to the USDA’s 2025 National Hemp Report, floral...
UK Insomnia Patients Report Improvements Following Medical Cannabis Use
Sleep quality is essential for overall physical and mental wellbeing. According to the Mayo Clinic, insomnia is “a common sleep disorder that can make it hard to fall asleep, hard to stay asleep, or cause early awakening.” Chronic insomnia is defined as persistent symptoms lasting more than one month. Globally, 16.2% of the population suffers from insomnia, while 7.9% experience severe insomnia, with higher prevalence in females across all age groups. Study Overview: Cannabis for Insomnia A team of public health researchers in the United Kingdom recently conducted a review of medical cannabis use among insomnia patients. Their findings were...
SYNBIOTIC SE Welcomes German Proposal to Modernize Industrial Hemp Laws
A Step Toward Greater Legal Certainty for Hemp in Germany Germany’s hemp and cannabis policy continues to evolve, with lawmakers introducing a new proposal aimed at strengthening the country’s industrial hemp sector. The draft amendment to the Consumer Cannabis Act (KCanG), presented by the Green Party in October 2025, seeks to remove outdated barriers and improve competitiveness within Europe’s hemp market. SYNBIOTIC SE, one of Europe’s leading cannabis and industrial hemp corporate groups, publicly welcomed the proposal. In a statement, the company described the measure as “an important step toward greater legal certainty, innovation, and competitiveness for the German hemp...


